| Product Code: ETC9568113 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Viral Vector Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Viral Vector Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Viral Vector Market - Industry Life Cycle |
3.4 Sweden Viral Vector Market - Porter's Five Forces |
3.5 Sweden Viral Vector Market Revenues & Volume Share, By Vector Type, 2021 & 2031F |
3.6 Sweden Viral Vector Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Viral Vector Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Viral Vector Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in biotechnology and pharmaceutical research in Sweden |
4.2.2 Growing demand for gene therapy and genetic research applications |
4.2.3 Favorable government regulations supporting the development and adoption of viral vectors in Sweden |
4.3 Market Restraints |
4.3.1 High cost associated with viral vector production and purification processes |
4.3.2 Limited availability of skilled professionals in viral vector manufacturing and research in Sweden |
5 Sweden Viral Vector Market Trends |
6 Sweden Viral Vector Market, By Types |
6.1 Sweden Viral Vector Market, By Vector Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Viral Vector Market Revenues & Volume, By Vector Type, 2021- 2031F |
6.1.3 Sweden Viral Vector Market Revenues & Volume, By Adeno-associated Virus (AAV), 2021- 2031F |
6.1.4 Sweden Viral Vector Market Revenues & Volume, By Adenovirus, 2021- 2031F |
6.1.5 Sweden Viral Vector Market Revenues & Volume, By Lentivirus, 2021- 2031F |
6.1.6 Sweden Viral Vector Market Revenues & Volume, By Retrovirus, 2021- 2031F |
6.1.7 Sweden Viral Vector Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Viral Vector Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Viral Vector Market Revenues & Volume, By Cell & Gene Therapy, 2021- 2031F |
6.2.3 Sweden Viral Vector Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.4 Sweden Viral Vector Market Revenues & Volume, By Biopharmaceutical & Pharmaceutical Discovery, 2021- 2031F |
6.3 Sweden Viral Vector Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Sweden Viral Vector Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.3 Sweden Viral Vector Market Revenues & Volume, By Academics & Research Institutes, 2021- 2031F |
6.3.4 Sweden Viral Vector Market Revenues & Volume, By CROs & CMOs, 2021- 2031F |
7 Sweden Viral Vector Market Import-Export Trade Statistics |
7.1 Sweden Viral Vector Market Export to Major Countries |
7.2 Sweden Viral Vector Market Imports from Major Countries |
8 Sweden Viral Vector Market Key Performance Indicators |
8.1 Research and development (RD) investment in gene therapy and genetic research projects in Sweden |
8.2 Number of clinical trials utilizing viral vectors in Sweden |
8.3 Adoption rate of viral vectors in biotech and pharmaceutical companies in Sweden |
9 Sweden Viral Vector Market - Opportunity Assessment |
9.1 Sweden Viral Vector Market Opportunity Assessment, By Vector Type, 2021 & 2031F |
9.2 Sweden Viral Vector Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Viral Vector Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Viral Vector Market - Competitive Landscape |
10.1 Sweden Viral Vector Market Revenue Share, By Companies, 2024 |
10.2 Sweden Viral Vector Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here